GRI Bio Inc

XNAS:GRI 3:59:54 PM EDT

2.06

-0.14 (-6.36%)

7:51:57 PM EDT: $2.05 -0.01 (-0.49%)

GRI Bio Inc Stock, XNAS:GRI

2223 Avenida De La Playa, Suite 208, La Jolla, California 92037

United States of America

Phone: +1.619.400.1170

Number of Employees: 4

http://www.gribio.com

Description

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.